| Primary |
| Narcolepsy |
22.0% |
| Sleep Apnoea Syndrome |
11.0% |
| Fatigue |
9.9% |
| Depression |
8.6% |
| Somnolence |
8.4% |
| Attention Deficit/hyperactivity Disorder |
5.3% |
| Multiple Sclerosis |
4.7% |
| Hypersomnia |
3.8% |
| Pain |
3.4% |
| Sleep Disorder |
3.1% |
| Hypertension |
2.9% |
| Diabetes Mellitus |
2.9% |
| Bipolar Disorder |
2.8% |
| Anxiety |
2.1% |
| Convulsion |
1.9% |
| Back Pain |
1.6% |
| Fibromyalgia |
1.5% |
| Chronic Fatigue Syndrome |
1.5% |
| Gastrooesophageal Reflux Disease |
1.4% |
| Blood Cholesterol Increased |
1.3% |
|
| Death |
9.2% |
| Rash |
9.2% |
| Suicidal Ideation |
8.6% |
| Stevens-johnson Syndrome |
7.2% |
| Vomiting |
6.1% |
| Convulsion |
5.8% |
| Suicide Attempt |
5.8% |
| Urticaria |
5.8% |
| Mania |
4.3% |
| Somnolence |
4.3% |
| Tremor |
4.3% |
| Transient Ischaemic Attack |
3.7% |
| Drug Ineffective |
3.5% |
| Maternal Exposure During Pregnancy |
3.5% |
| Off Label Use |
3.5% |
| Headache |
3.2% |
| Nausea |
3.2% |
| Tachycardia |
3.2% |
| Drug Interaction |
2.9% |
| Syncope |
2.9% |
|
| Secondary |
| Narcolepsy |
14.6% |
| Pain |
9.6% |
| Depression |
8.6% |
| Sleep Apnoea Syndrome |
8.5% |
| Fatigue |
7.2% |
| Drug Use For Unknown Indication |
6.8% |
| Somnolence |
6.3% |
| Attention Deficit/hyperactivity Disorder |
5.8% |
| Multiple Sclerosis |
5.4% |
| Diabetes Mellitus |
3.7% |
| Product Used For Unknown Indication |
3.3% |
| Bipolar Disorder |
2.6% |
| Blood Cholesterol Increased |
2.5% |
| Hypertension |
2.4% |
| Thyroid Disorder |
2.3% |
| Hypersomnia |
2.2% |
| Restless Legs Syndrome |
2.2% |
| Fibromyalgia |
2.1% |
| Gastrooesophageal Reflux Disease |
2.1% |
| Insomnia |
1.7% |
|
| Tremor |
11.8% |
| Fibromyalgia |
8.4% |
| Somnolence |
6.6% |
| Weight Decreased |
6.3% |
| Vomiting |
5.6% |
| Drug Ineffective |
5.2% |
| Weight Increased |
5.2% |
| Drug Interaction |
4.9% |
| Drug Toxicity |
4.9% |
| Nausea |
4.2% |
| Rash |
4.2% |
| Stevens-johnson Syndrome |
4.2% |
| Talipes |
4.2% |
| Psychotic Disorder |
3.8% |
| Suicidal Ideation |
3.8% |
| White Blood Cell Count Increased |
3.8% |
| Tourette's Disorder |
3.5% |
| Mania |
3.1% |
| Speech Disorder |
3.1% |
| Tic |
3.1% |
|
| Concomitant |
| Product Used For Unknown Indication |
21.7% |
| Multiple Sclerosis |
20.6% |
| Drug Use For Unknown Indication |
14.5% |
| Depression |
7.5% |
| Pain |
5.7% |
| Fatigue |
4.7% |
| Hypertension |
3.2% |
| Anxiety |
2.4% |
| Rheumatoid Arthritis |
2.2% |
| Insomnia |
2.2% |
| Gastrooesophageal Reflux Disease |
1.9% |
| Muscle Spasms |
1.8% |
| Fibromyalgia |
1.7% |
| Osteoporosis |
1.6% |
| Sleep Disorder |
1.6% |
| Relapsing-remitting Multiple Sclerosis |
1.6% |
| Blood Cholesterol Increased |
1.4% |
| Migraine |
1.3% |
| Bipolar Disorder |
1.3% |
| Diabetes Mellitus |
1.2% |
|
| Vomiting |
11.3% |
| Weight Decreased |
10.0% |
| Weight Increased |
9.3% |
| Urinary Tract Infection |
7.5% |
| Vision Blurred |
6.0% |
| Pain |
5.8% |
| Somnolence |
5.7% |
| Multiple Sclerosis Relapse |
4.7% |
| Tremor |
4.7% |
| Nausea |
4.5% |
| Fatigue |
4.4% |
| Suicidal Ideation |
3.3% |
| White Blood Cell Count Decreased |
3.1% |
| Drug Ineffective |
2.9% |
| Pyrexia |
2.9% |
| Pain In Extremity |
2.8% |
| Progressive Multifocal Leukoencephalopathy |
2.8% |
| Syncope |
2.8% |
| Multiple Sclerosis |
2.7% |
| Pneumonia |
2.7% |
|
| Interacting |
| Obsessive-compulsive Disorder |
10.9% |
| Depression |
9.3% |
| Fatigue |
8.5% |
| Insomnia |
8.5% |
| Narcolepsy |
7.7% |
| Contraception |
6.9% |
| Osteopenia |
6.9% |
| Somnolence |
6.9% |
| Tourette's Disorder |
6.0% |
| Fibromyalgia |
3.6% |
| Smoking Cessation Therapy |
3.6% |
| Drug Use For Unknown Indication |
3.2% |
| Multiple Sclerosis |
3.2% |
| Raynaud's Phenomenon |
3.2% |
| Neuralgia |
2.4% |
| Neck Pain |
2.0% |
| Pain |
2.0% |
| Swelling |
2.0% |
| Constipation |
1.6% |
| Post-traumatic Stress Disorder |
1.6% |
|
| Tourette's Disorder |
26.8% |
| Rash Erythematous |
10.7% |
| Swelling |
8.9% |
| Drug Interaction |
5.4% |
| Musculoskeletal Stiffness |
5.4% |
| Narcolepsy |
5.4% |
| Arthralgia |
3.6% |
| Epistaxis |
3.6% |
| Lupus-like Syndrome |
3.6% |
| Prothrombin Level Decreased |
3.6% |
| Rash |
3.6% |
| Weight Increased |
3.6% |
| White Blood Cell Count Increased |
3.6% |
| Balance Disorder |
1.8% |
| Fatigue |
1.8% |
| Haemorrhage |
1.8% |
| Headache |
1.8% |
| Inhibitory Drug Interaction |
1.8% |
| Pain |
1.8% |
| Sedation |
1.8% |
|
